These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9437759

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
    Chen CS, Jounaidi Y, Waxman DJ.
    Drug Metab Dispos; 2005 Sep; 33(9):1261-7. PubMed ID: 15919850
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and bioavailability of stereoisomeric analogues of ifosfamide.
    Sloderbach A, Hładoń B, Laskowska H.
    Acta Physiol Hung; 1996 Sep; 84(4):459-60. PubMed ID: 9328631
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic-stereoselective differentiation of some isomeric analogues of ifosfamide.
    Sloderbach A, Hładoń B, Sochacki M, Kinas R, Kuśnierczyk H, Laskowska H.
    Pol J Pharmacol; 1997 Sep; 49(6):463-9. PubMed ID: 9566050
    [Abstract] [Full Text] [Related]

  • 9. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1986 Sep; 34(3):285-91. PubMed ID: 3592932
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, in vitro metabolic studies, and antitumour activity of methyl analogues of ifosfamide.
    Misiura K, Kardacka K, Kusnierczyk H.
    Arch Pharm (Weinheim); 2001 Sep; 334(8-9):291-4. PubMed ID: 11688140
    [Abstract] [Full Text] [Related]

  • 11. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
    Storme T, Deroussent A, Mercier L, Prost E, Re M, Munier F, Martens T, Bourget P, Vassal G, Royer J, Paci A.
    J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
    [Abstract] [Full Text] [Related]

  • 12. Studies on the side-chain hydroxylation of ifosfamide and its bromo analogue.
    Misiura K, Kinas RW, Kuśnierczyk H.
    Bioorg Med Chem Lett; 2002 Feb 11; 12(3):427-31. PubMed ID: 11814813
    [Abstract] [Full Text] [Related]

  • 13. Influence of inducers of monooxygenases on cytotoxic efficiency of ellipticine on leukemia L1210 cells.
    Lesca P, Monsarrat B, Cros S, Paoletti C.
    J Natl Cancer Inst; 1981 Oct 11; 67(4):871-6. PubMed ID: 6944554
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, toxicity, pharmacokinetics, and in vitro metabolism of the enantiomers of ifosfamide in mice.
    Masurel D, Houghton PJ, Young CL, Wainer IW.
    Cancer Res; 1990 Jan 15; 50(2):252-5. PubMed ID: 2295063
    [Abstract] [Full Text] [Related]

  • 15. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I, Bakopoulou A, Papageorgiou A, Iakovidou Z, Mioglou E, Nikolaropoulos S, Mourelatos D, Lialiaris T.
    Mutat Res; 2009 Apr 30; 675(1-2):51-9. PubMed ID: 19386248
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
    Kutscher B, Niemeyer U, Engel J, Kleemann A, Hilgard P, Pohl J, Scheffler G.
    Arzneimittelforschung; 1995 Mar 30; 45(3):323-6. PubMed ID: 7741794
    [Abstract] [Full Text] [Related]

  • 17. Design of highly active analogues of the pyrrolo[1,2-a]benzimidazole antitumor agents.
    Craigo WA, LeSueur BW, Skibo EB.
    J Med Chem; 1999 Aug 26; 42(17):3324-33. PubMed ID: 10464019
    [Abstract] [Full Text] [Related]

  • 18. [Separation and pharmaco-toxicological studies of the enantiomers of Ifosfamide].
    Blaschke G, Hilgard P, Maibaum J, Niemeyer U, Pohl J.
    Arzneimittelforschung; 1986 Oct 26; 36(10):1493-5. PubMed ID: 3814210
    [Abstract] [Full Text] [Related]

  • 19. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A, Iwata T, Yamaguchi K, Shiratori O, Harada M.
    Cancer Treat Rep; 1976 Apr 26; 60(4):361-8. PubMed ID: 1277212
    [Abstract] [Full Text] [Related]

  • 20. (S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice.
    Misiura K, Kinas RW, Kuśnierczyk H, Radzikowski C, Stec WJ.
    Anticancer Drugs; 2001 Jun 26; 12(5):453-8. PubMed ID: 11395573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.